|
|
Christensen, L. P. (1999). Airborne Compositae dermatitis: monoterpenes and no parthenolide are released from flowering Tanacetum parthenium (feverfew) plants. Archives of Dermatological Res, 291 (7-8), 425-31. Palevitch, D., Earon, G., & Carasso, R. (1997). Feverfew as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytotherapy Research, 11, 508-511. Kuhn, M. (1999). Complementary Therapies for Health Care Providers. Lippincott William & Wilkins. O'Hara, M. (1998). A review of 12 commonly used medicinal herbs. Archives of Family Medicine, 158(20), 2200-11. Jellin, J. (1999). Prescriber’s Letter: Therapeutic Uses of Herbs. Stockton, California. Rotblatt, M. D. (1999). Cranberry, feverfew, horse chestnut, and kava. Western Journal of Medicine. 171(3), 195-8. Tyler V. (1994). Herbs of Choice: The therapeutic use of phytomedicinals. New York: Haworth Press. Tyler V. (1994). What pharmacists should know about herbal remedies. Journal of American Pharmacy Association, 36 (1) 29-37. Vogler, B. K. (1998). Feverfew as a preventive treatment for migraine: a systematic review. Cephalalgia. 18(10), 704-8. Williams, C. A. (1999). The flavonoids of Tanacetum parthenium and T. Vulgare and their anti-inflammatory properties. Phytochemistry, 51(3): 417-23.Zink, T. (1998). Herbal 'health' products: what family physicians need to know. American Family Physician, 58(5): 1133-40. |
|
|